Quick Answer
ABEONA THERAPEUTICS INC. reported Long-Term Debt of $7.81 million for fiscal year 2025.
ABEONA THERAPEUTICS INC. Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $7.81M | -40.1% |
| 2024 | $13.04M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $10.86M | -23.5% | -22.4% |
| June 30, 2025 | $14.01M | -13.2% | +25.7% |
| March 31, 2025 | $11.14M | -38.4% | -14.6% |
| December 31, 2024 | $13.04M | — | -8.2% |
| September 30, 2024 | $14.21M | — | -11.9% |
| June 30, 2024 | $16.13M | — | -10.8% |
| March 31, 2024 | $18.08M | — | — |
- ABEONA THERAPEUTICS INC. showed a decrease of -40.1% in Long-Term Debt compared to the prior fiscal year.
- Over the 2024–2025 period, ABEONA THERAPEUTICS INC.’s long-term debt has declined by 40.1% (from $13.04 million to $7.81 million).
- The most recent figure is from ABEONA THERAPEUTICS INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: